Position in ELAN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,318,848
+$651,995 QoQ
Shares Held
1,434,135
-3.6% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.91488597656426.ToString("F0")%
Shared 0.ToString("F0")%
None 1.0851140234357297.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Derivatives in ELAN
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$2,263,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. ELAN ranks #16 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,730,785 | $441,016,092 | |
| 2 | VTRS |
Viatris Inc
|
13,717,622 | $185,325,071 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,826,245 | $145,366,498 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
5,618,728 | $104,058,841 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,409,165 | $73,431,349 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
114,419 | $67,848,177 | |
| 7 | ALKS |
Alkermes plc.
|
1,882,178 | $66,553,812 | |
| 8 | HLN |
Haleon plc
|
6,127,452 | $61,335,793 |
All Filings in ELAN
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,318,848 | 1,434,135 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,666,853 | 1,487,709 | Shares | Defined | 2026-03-25 | |
| 2025-12-31 | $2,263,000 | 100,000 | Put | Defined | 2026-03-25 | |
| 2025-09-30 | $27,816,218 | 1,381,143 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $49,400,515 | 3,459,420 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $50,267,637 | 4,787,394 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $28,355,829 | 2,341,522 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $20,962,614 | 1,426,999 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $40,905,109 | 2,834,727 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,290,106 | 1,123,471 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $18,159,149 | 1,218,735 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $62,110,675 | 5,525,861 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $90,496,659 | 8,995,692 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $92,583,061 | 9,849,262 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $127,125,464 | 10,403,066 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,455,939 | 197,900 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $23,668,611 | 1,907,221 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $199,425,879 | 10,159,240 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $315,825,342 | 12,105,226 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $299,808,106 | 10,564,063 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $301,392,068 | 9,450,990 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $345,056,467 | 9,946,857 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $257,275,050 | 8,735,995 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $256,460,604 | 8,361,937 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $233,657,070 | 8,365,810 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $143,265,534 | 6,679,046 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $2,528,955 | 117,900 | Put | Defined | 2020-08-12 | |
| 2020-03-31 | $158,252,047 | 7,067,979 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $1,119,500 | 50,000 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||